PetMed Express reported a significant miss in Q4 earnings with an EPS of $-0.25, which is 278.57% below estimates. Additionally, revenue was down $3.60 million from the same period last year. This negative financial performance is likely to have a short-term negative impact on the stock price, as investors may lose confidence in the company's ability to meet expectations.